Blair William & Co. IL Has $15.55 Million Holdings in CVS Health Co. (NYSE:CVS)

Blair William & Co. IL decreased its stake in shares of CVS Health Co. (NYSE:CVS) by 36.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 263,269 shares of the pharmacy operator’s stock after selling 149,538 shares during the period. Blair William & Co. IL’s holdings in CVS Health were worth $15,549,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Ables Iannone Moore & Associates Inc. bought a new position in shares of CVS Health in the fourth quarter valued at approximately $32,000. Creekmur Asset Management LLC acquired a new position in CVS Health during the 4th quarter worth $34,000. Steph & Co. grew its position in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of CVS Health in the fourth quarter worth about $36,000. Finally, Scarborough Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter worth about $37,000. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have commented on CVS. Evercore ISI dropped their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Barclays dropped their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Monday. Royal Bank of Canada restated an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Finally, Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Eleven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $72.10.

CVS Health Stock Down 0.0 %

CVS opened at $58.40 on Friday. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The firm has a market cap of $73.31 billion, a price-to-earnings ratio of 10.26, a PEG ratio of 0.79 and a beta of 0.53. The firm’s 50-day simple moving average is $58.34 and its 200-day simple moving average is $62.71. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business posted $2.21 earnings per share. Equities research analysts anticipate that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a $0.665 dividend. The ex-dividend date was Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.55%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.